Live Breaking News & Updates on அமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யா ஆன்

Stay updated with breaking news from அமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யா ஆன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Reddys surges 5% as Sputnik V gets expert panel nod for emergency use

Dr Reddys surges 5% as Sputnik V gets expert panel nod for emergency use
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Gamaleya National Research Institute Of Epidemiology , Ministry Of Health Russia On , Russian Direct Investment Fund , Drugs Controller General , Emergency Use Authorization , Gamaleya National Research Institute , அமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யா ஆன் , ரஷ்ய நேரடி முதலீடு நிதி , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , அவசரம் பயன்பாடு அங்கீகாரம் ,

Panacea Biotec share rises 20% on pact to make 100 million doses of Sputnik V vaccine per year

Story
Panacea Biotec share rises 20% on pact to make 100 million doses of Sputnik V vaccine per year
Share of the pharma firm rose 19.99% to Rs 220.85 against previous close of Rs 184.40 on BSE. The stock opened with a gain of 15.68% at Rs 212.90
BusinessToday.In | April 6, 2021 | Updated 10:40 IST
Panacea Biotec stock is trading higher than 5 day, 20 day, 50 day, 100 day and 200 day moving averages.
Panacea Biotec share rose 20% today after the drug maker said it has inked pact with Russian Direct Investment Fund (RDIF) to produce 100 million doses per year of the Sputnik V COVID-19 vaccine in India. Share of the pharma firm rose 19.99% to Rs 220.85 against previous close of Rs 184.40 on BSE. ....

Baddi Himachal Pradesh , Kirill Dmitriev , Rajesh Jain , Russia Gamaleya National Research Institute Of Epidemiology , Ministry Of Health Russia On , Russian Direct Investment Fund , Panacea Biotec , Himachal Pradesh , Gamaleya National Research Institute , Panacea Biotec Share , Panacea Biotec Share Rises , Russian Direct Investment Fund Rdif , பாடதி இமாச்சல் பிரதேஷ் , ராஜேஷ் ஜெயின் , அமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யா ஆன் , ரஷ்ய நேரடி முதலீடு நிதி , சஞ்சீவி பயோடெக் , இமாச்சல் பிரதேஷ் , சஞ்சீவி பயோடெக் பகிர் , சஞ்சீவி பயோடெக் பகிர் உயர்கிறது ,

COVID-19 vaccination: Uddhav Thackeray asks PM to reduce eligible age to 25 yrs : Bulletin: Business Today

Loading the player.
Rashi Bisaria | April 6, 2021
COVID-19 vaccination: Uddhav Thackeray asks PM Modi to reduce eligible age to 25 yrsMaharashtra Chief Minister Uddhav Thackeray has written a letter to Prime Minister Narendra Modi asking to reduce the age for getting COVID-19 vaccination to 25 years. Saying that the second wave of the coronavirus is much stronger than the first wave in the state, Thackeray said Maharashtra is taking up vaccination at a rapid pace and is the number 1 state in the country in terms of COVID-19 vaccine doses administered.
Meesho becomes latest entrant to Indian unicorn club with $300 million fundraiseIndian social commerce platform Meesho has entered the unicorn club after raising $300 million in the latest round of funding. The Series E funding round, led by SoftBank Group s Vision Fund 2, saw the valuation of the Bengaluru-based start-up rise to $2.1 billion from around $700 million in 2019. ....

Saudi Arabia , Ar Riya , Narendra Modi , Uddhav Thackeray , Goldman Sachs , Ministry Of Health Russia On , Russian Direct Investment Fund , Russia Gamaleya National Research Institute Of Epidemiology , Softbank Group Vision Fund , Chief Minister Uddhav Thackeray , Prime Minister Narendra Modi , Softbank Group , Vision Fund , Panacea Biotec , Gamaleya National Research Institute , Care Ratings , Falcon Edge The , Unicorn Meesho , Covid 19 , Sputnik V , Covid 19 Vaccination , Indian Economy , சவுதி அரேபியா , ஆர் ரியா , நரேந்திர மோடி , உத்தவ் தாக்கரே ,

COVID-19: Panacea Biotec to produce 100 million doses of Sputnik V in India annually

COVID-19: Panacea Biotec to produce 100 million doses of Sputnik V in India annually
Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF.
BusinessToday.In | April 5, 2021 | Updated 21:34 IST
Panacea Biotec MD Rajesh Jain said the company will produce Sputnik V in its internationally accredited facilities.
Panacea Biotec on Monday said it has entered into an agreement with the Russian Direct Investment Fund (RDIF) to produce 100 million doses of COVID-19 vaccine Sputnik V in India annually.
Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF, the New-Delhi based company said in a release. Panacea Biotec has production facilities at Baddi (Himachal Pradesh), Lalru (Punjab) and Delhi. ....

Baddi Himachal Pradesh , Kirill Dmitriev , Rajesh Jain , Stelis Biopharma , Virchow Biotech Private , India Subject Expert Committee , Ministry Of Health Russia On , Russian Direct Investment Fund , Russia Gamaleya National Research Institute Of Epidemiology , Panacea Biotec , Himachal Pradesh , Gamaleya National Research Institute , Drug Controller General , Subject Expert Committee , Gland Pharma , Virchow Biotech Private Limited , Sputnik V , Biotec Rdif , Panacea Biotec Sputnik V , பாடதி இமாச்சல் பிரதேஷ் , ராஜேஷ் ஜெயின் , இந்தியா பொருள் நிபுணர் குழு , அமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யா ஆன் , ரஷ்ய நேரடி முதலீடு நிதி , சஞ்சீவி பயோடெக் , இமாச்சல் பிரதேஷ் ,

COVID-19: Panacea Biotec to produce 100 million doses of Sputnik V in India annually

COVID-19: Panacea Biotec to produce 100 million doses of Sputnik V in India annually
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Baddi Himachal Pradesh , Kirill Dmitriev , Rajesh Jain , Stelis Biopharma , Virchow Biotech Private , India Subject Expert Committee , Ministry Of Health Russia On , Russian Direct Investment Fund , Russia Gamaleya National Research Institute Of Epidemiology , Panacea Biotec , Himachal Pradesh , Gamaleya National Research Institute , Drug Controller General , Subject Expert Committee , Gland Pharma , Virchow Biotech Private Limited , பாடதி இமாச்சல் பிரதேஷ் , ராஜேஷ் ஜெயின் , இந்தியா பொருள் நிபுணர் குழு , அமைச்சகம் ஆஃப் ஆரோக்கியம் ரஷ்யா ஆன் , ரஷ்ய நேரடி முதலீடு நிதி , சஞ்சீவி பயோடெக் , இமாச்சல் பிரதேஷ் , மருந்து கட்டுப்படுத்தி ஜநரல் , பொருள் நிபுணர் குழு , சுரப்பி பார்மா ,